This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics Europe
27 - 29 May, 2026
Congress CenterBasel Switzerland

Dr. Lucas Picavet, PhD
Senior Scientist at Gyes BV
Speaker

Profile

Lucas Picavet, PhD, is Senior Scientist Immunology at Gyes, where he leads multispecific antibody programs in immuno-oncology and autoimmunity. His work focuses on avidity-based design to enable selective and conditional immune cell modulation. Previously, he worked at Genmab on antibody discovery and engineering strategies, and at Gadeta on γδTCR engineered T-cell therapies, optimizing co-stimulation and T-cell persistence. Lucas completed his PhD at the Center for Translational Immunology (Utrecht), studying epigenetic and epitranscriptomic regulation of immune activation in autoimmunity.

Agenda Sessions

  • Avidity Engineering Enables Conditional and Multifunctional Antibody Therapeutics

    11:00